Karin Warburg

Statistics

Publications

Citations

397

H-Index

Active since

2010

Affiliations

Max Planck Institute of Molecular Physiology(Current)

Chemical Genomics Centre

TU Dortmund University

University of Münster

Karin Warburg is an author at Max Planck Institute of Molecular Physiology specializing in novel antibacterial agents, synthetic medicinal chemistry, and pulmonary tuberculosis.

Publications per year

2010–2011

Publications

Identification of Thiazolidinones Spiro‐Fused to Indolin‐2‐ones as Potent and Selective Inhibitors of the <i>Mycobacterium tuberculosis</i> Protein Tyrosine Phosphatase B

Viktor V. Vintonyak, Karin Warburg, Holger Kruse et al. · Angewandte Chemie International Edition · 2010 · 292 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Identification and further development of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B

Viktor V. Vintonyak, Karin Warburg, Björn Over et al. · Tetrahedron · 2011 · 53 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Identification of Thiazolidinones Spiro‐Fused to Indolin‐2‐ones as Potent and Selective Inhibitors of the <i>Mycobacterium tuberculosis</i> Protein Tyrosine Phosphatase B

Viktor V. Vintonyak, Karin Warburg, Holger Kruse et al. · Angewandte Chemie · 2010 · 52 citations

Medicine, Medicinal Chemistry, Pharmacology +10

1–3 of 3